From Bench to Bedside and Beyond: Infusing Patient Perspectives Across Pfizer

Emma Andrews, PharmD is Pfizer’s Vice President,  Global Patient Advocacy, leading the organization’s work to embed the patient perspective across all Pfizer’s efforts – from bench to bedside, and beyond. A registered pharmacist, Dr Andrews is passionate about helping people live longer, healthier, and more productive lives. In her current role, Dr Andrews works with internal and external stakeholders to advance patient-focused programs across the enterprise.Dr Andrews joined Pfizer, Inc in 1999 and has held different positions with increasing responsibility in Operations, Research and Strategy. She began her work in medical affairs as the Regional Medical Therapeutic Area Lead-Diversified Portfolio for Latin America, responsible for developing medical strategies for Latin America and enhancing medical communication between Pfizer and the region’s stakeholders. Most recently, Dr Andrews was the Senior Director US/Global Medical Affairs Team Lead for the Women’s Health Franchise.Prior to that role, Dr Andrews was a Director in External Medical Affairs responsible for engaging with external partners critical to Pfizer’s business with the goal of advancing areas of mutual interest. She was also a member of the Clinical Pharmacology team in New York working in the infectious diseases therapeutic area where her focus was HIV and Malaria..Dr Andrews is motivated by Pfizer’s common purpose: to bring breakthroughs to patients, regardless of where they are in the world. Her experience growing up in Uganda and Cote d’Ivoire, has shaped her commitment to reducing healthcare disparities, improving health literacy, and advancing health equity in all she does.Dr Andrews completed her Doctor of Pharmacy, as well as her Bachelor of Pharmacy, at the Massachusetts College of Pharmacy and Health Science.

Cindy Geoghegan is a patient advocate, advisor and activist with over 30 years of health policy and communications experience, having held senior staff and board positions with several leading cancer non-profit organizations including Susan G. Komen, Y-ME National Breast Cancer Organization and others. She began her advocacy career shortly after her breast cancer diagnosis in 1995. Ms Geoghegan has provided the patient perspective on research teams and projects funded by Stand Up to Cancer, the National Cancer Institute, the American Association for Cancer Research, the American Society of Clinical Oncology, the Patient-Centered Outcomes Research Institute and has served on the steering committee of the Clinical Trials Transformation Initiative (CTTI), the Duke University/FDA joint venture focused on more efficient clinical trials. Ms Geoghegan is currently a member of the Johns Hopkins Kimmel Cancer Center’s External Advisory Board, and on the Founding Members Council for the Digital Medicine Society, where she also serves on its research committee. Ms Geoghegan has co-authored more than a dozen publications with researchers focused on patient preferences and improving patient outcomes.